• Home
  • Search Results
  • Low toxic dispersive liquid-liquid microextraction using halosolvents for extraction of polycyclic aromatic hydrocarbons in water samples.

Low toxic dispersive liquid-liquid microextraction using halosolvents for extraction of polycyclic aromatic hydrocarbons in water samples.

Journal of chromatography. A (2010-07-29)
Mei-I Leong, Chu-Chi Chang, Ming-Ren Fuh, Shang-Da Huang
ABSTRACT

A low toxic dispersive liquid-liquid microextraction (LT-DLLME) combined with gas chromatography-mass spectrometry (GC-MS) had been developed for the extraction and determination of 16 polycyclic aromatic hydrocarbons (PAHs) in water samples. In normal DLLME assay, chlorosolvent had been widely used as extraction solvents; however, these solvents are environmental-unfriendly. In order to solve this problem, we proposed to use low toxic bromosolvent (1-bromo-3-methylbutane, LD(50) 6150mg/kg) as the extraction solvent. In this study we compared the extraction efficiency of five chlorosolvents and thirteen bromo/iodo solvents. The results indicated that some of the bromo/iodo solvents showed better extraction and had much lower toxicity than chlorosolvents. We also found that propionic acid is used as the disperser solvent, as little as 50microL is effective. Under optimum conditions, the range of enrichment factors and extraction recoveries of tap water samples are ranging 372-1308 and 87-105%, respectively. The linear range is wide (0.01-10.00microgL(-1)), and the limits of detection are between 0.0003 and 0.0078microgL(-1) for most of the analytes. The relative standard deviations (RSD) for 0.01microgL(-1) of PAHs in tap water were in the range of 5.1-10.0%. The performance of the method was gauged by analyzing samples of tap water, sea water and lake water samples.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
1-Bromo-3-methylbutane, 96%

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.